This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Pathological Gambling
and you are
between 21 and 75
years old
This is a second phase trial assessing
efficacy and side effects of the new treatment.
Show me locations

The purpose

The goal of the proposed study is to evaluate the efficacy and safety of tolcapone in pathological gambling.

Provided treatments

  • Drug: Tolcapone
Tris trial is registered with FDA with number: NCT00927563. The sponsor of the trial is University of Chicago and it is looking for 24 volunteers for the current phase.
Official trial title:
Tolcapone Treatment of Pathological Gambling: An Open-Label Study